The Portnoy Law Firm has initiated a class action lawsuit targeting Quantum Biopharma, Ltd. on behalf of investors who acquired company securities during a nearly five-year period spanning January 6, 2021 through October 15, 2025. The legal filing alleges that defendants engaged in coordinated market manipulation tactics involving spoofed sell orders—a practice wherein false trading signals are placed to create misleading market conditions.
According to the complaint, the alleged manipulation scheme was designed to artificially suppress the company's stock price, enabling defendants to acquire shares at depressed valuations. The lawsuit contends that legitimate investors were simultaneously deceived into divesting their holdings at artificially diminished prices, resulting in substantial losses during the alleged manipulation period.
The case represents one of several enforcement actions targeting market manipulation practices in the equities markets. Shareholders who believe they sustained losses during the specified timeframe may be eligible to participate in the class action. The litigation is ongoing, and no determinations regarding liability or damages have been made at this stage.